SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-002152
Filing Date
2018-02-15
Accepted
2018-02-15 07:36:48
Documents
81
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alny-10k_20171231.htm 10-K 4245456
2 EX-21.1 alny-ex211_51.htm EX-21.1 19305
3 EX-23.1 alny-ex231_52.htm EX-23.1 2936
4 EX-31.1 alny-ex311_50.htm EX-31.1 18232
5 EX-31.2 alny-ex312_49.htm EX-31.2 18328
6 EX-32.1 alny-ex321_48.htm EX-32.1 7206
7 EX-32.2 alny-ex322_47.htm EX-32.2 7105
8 GRAPHIC g2018021423491781787968.jpg GRAPHIC 33983
9 GRAPHIC g2018021423490664687967.jpg GRAPHIC 30571
  Complete submission text file 0001564590-18-002152.txt   14125030

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT alny-20171231.xml EX-101.INS 3250724
11 XBRL TAXONOMY EXTENSION SCHEMA alny-20171231.xsd EX-101.SCH 79164
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20171231_cal.xml EX-101.CAL 77683
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20171231_def.xml EX-101.DEF 283678
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20171231_lab.xml EX-101.LAB 600244
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20171231_pre.xml EX-101.PRE 466954
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36407 | Film No.: 18616157
SIC: 2834 Pharmaceutical Preparations